Pages that link to "Q42439610"
Jump to navigation
Jump to search
The following pages link to Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. (Q42439610):
Displaying 16 items.
- Hypercholesterolemia Tunes Hematopoietic Stem/Progenitor Cells for Inflammation and Atherosclerosis (Q26742064) (← links)
- New Markers of Inflammation and Endothelial Cell Activation (Q28211342) (← links)
- Cross-talk between endothelin-1 and mineral metabolism in hemodialysis patients: a cross-sectional study. (Q33918306) (← links)
- C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells (Q34078577) (← links)
- Adipokines: molecular links between obesity and atheroslcerosis (Q34384883) (← links)
- Vascular effects of TZDs: new implications (Q34567958) (← links)
- The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects (Q34919524) (← links)
- C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation (Q35558796) (← links)
- C-reactive protein in end-stage renal disease: are there reasons to measure it? (Q35997686) (← links)
- The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis (Q36405110) (← links)
- C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile? (Q36901513) (← links)
- Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia (Q37105230) (← links)
- Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies (Q37923226) (← links)
- Serum glucose level at hospital admission correlates with left ventricular systolic dysfunction in nondiabetic, acute coronary patients: the Hellenic Heart Failure Study (Q43050348) (← links)
- Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects (Q46177871) (← links)
- Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction. (Q55070207) (← links)